» Articles » PMID: 35148736

Tranexamic Acid Combined with Compression Dressing Reduces Blood Loss in Gluteal Muscle Contracture Surgery

Overview
Journal BMC Surg
Publisher Biomed Central
Specialty General Surgery
Date 2022 Feb 12
PMID 35148736
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Blood loss and incision-related complications caused by the surgical procedure to release gluteal muscle contracture (GMC) put negative effects on the surgical outcomes. Current procedures to prevent blood loss and complications are not satisfactory. The current study aimed to determine whether tranexamic acid (TXA) in combination with pressure dressing reduce the amount of blood loss, the rate of incision-related complications, and the rate of readmission for patients undergoing surgeries to release GMC.

Methods: 49 GMC patients were finally included in the study and were randomly divided into two groups: study group and control group. Patients in both groups received minimally invasive surgery to release GMC except that in the study group, patients were administered a dosage of 20 mg/kg of intravenous TXA preoperatively, and 2 subsequent dosages of TXA at 10 mg/kg at two time points: 3 and 6 h after the first dose. Gauze soaked with TXA was used to pack the wound for 10 min before the incision closure. Then the wound was pressure-wrapped with a hip-spica bandage for 24 h after the surgery in the study group.

Results: The level of UBL in the study group was significantly lower compared to that in the control group. Similar results were also found for UMHD and UMAD. The incision-related postoperative complications were greatly decreased in the study group compared to those of the control group as well. So was the 30-day readmission rate. All patients in both groups reached "excellent" or "good" level with respect to the postoperative function evaluation.

Conclusions: Intravenous and topical application of TXA combined with 24 h pressure hip-spica bandage reduces perioperative blood loss, rate of incision-related complications, and the rate of readmission for GMC patients undergoing minimally invasive surgical releasing procedure. Trial Registration Chinese Clinical and Trial Registry ChiCTR2000039216, registration date 2020/10/22, retrospectively registered.

Citing Articles

Minimally invasive treatment of grade I and II gluteal muscle contracture using a self-made special cutter combined with a specialized compression hemostasis device.

Yang Y, Peng Z, Shi L, Wang Y, Wang Y, Ge B BMC Musculoskelet Disord. 2024; 25(1):1024.

PMID: 39702133 PMC: 11660755. DOI: 10.1186/s12891-024-08150-1.

References
1.
Franchini M, Mengoli C, Marietta M, Marano G, Vaglio S, Pupella S . Safety of intravenous tranexamic acid in patients undergoing majororthopaedic surgery: a meta-analysis of randomised controlled trials. Blood Transfus. 2018; 16(1):36-43. PMC: 5770313. DOI: 10.2450//2017.0219-17. View

2.
Rai S, Meng C, Wang X, Chaudhary N, Jin S, Yang S . Gluteal muscle contracture: diagnosis and management options. SICOT J. 2017; 3:1. PMC: 5217396. DOI: 10.1051/sicotj/2016036. View

3.
Yue C, Kang P, Yang P, Xie J, Pei F . Topical application of tranexamic acid in primary total hip arthroplasty: a randomized double-blind controlled trial. J Arthroplasty. 2014; 29(12):2452-6. DOI: 10.1016/j.arth.2014.03.032. View

4.
Yang Z, Chen W, Wu L . Effectiveness and safety of tranexamic acid in reducing blood loss in total knee arthroplasty: a meta-analysis. J Bone Joint Surg Am. 2012; 94(13):1153-9. DOI: 10.2106/JBJS.K.00873. View

5.
Lin S, Chen C, Fu Y, Huang P, Chang J, Huang H . Corrigendum to "The Efficacy of Combined Use of Intraarticular and Intravenous Tranexamic Acid on Reducing Blood Loss and Transfusion Rate in Total Knee Arthroplasty" [Journal of Arthroplasty (2015) 776-780]. J Arthroplasty. 2019; 34(5):1047. DOI: 10.1016/j.arth.2019.01.056. View